Hayashibara Brings Back "Trehalose Symposium" to Reveal Its Game-changing Versatilities in Human Biochemistry

PR Newswire
October 4, 2022 — 14:00 CST

UNLOCK DATA
Subscribe & Access the Best Data and Intelligence on Chinese Venture Capital and Tech

Want to read this important story?

Access thousands of news articles and data posts over the past 9 years!

Already have an account or paid subscription? Log in

Related Topics: biotech corporate social responsibility japan Papau New Guinea pharmaceutical Tokyo Vaccine

Related News:

Invitation for Interest to Participate for Development of the HKSTP San Tin Technopole

June 11, 2025 — 17:10

Goodstack Unveils its All-in-One Impact Suite to Transform Corporate Giving and Social Impact

April 23, 2025 — 02:17

China High Speed Transmission Equipment Group Commences Legal Proceedings for Fund Misappropriation of RMB 6.64 Billion

April 1, 2025 — 12:31

Luye Pharma’s Rivastigmine Twice Weekly Transdermal Patch Approved for Marketing in Japan for the Treatment of Alzheimer’s Dementia

March 31, 2025 — 21:35

A new report by McKinsey & Company and the World Federation of the Sporting Goods Industry explores the state of the industry and growth themes for 2025 and beyond

March 5, 2025 — 23:00

A new report by McKinsey & Company and the World Federation of the Sporting Goods Industry explores the state of the industry and growth themes for 2025 and beyond

March 5, 2025 — 23:00

Indianapolis Prize Names Ugandan Wild Cat Protector Winner of Second Emerging Conservationist Award

March 4, 2025 — 22:30

Starlab Advances to Full Development After Successfully Completing Key NASA Milestone

March 4, 2025 — 05:16

Bambusa Therapeutics Announces First Subject Dosed in Phase 1 Clinical Trial of BBT001, a Novel Multi-Targeting, Half-Life Extended Bispecific Antibody for the Treatment of Atopic Dermatitis and Other Inflammatory Skin Diseases

February 28, 2025 — 22:58

Franchising and Licensing Asia (FLAsia) 2024